Aurobindo Pharma soars as its US arm emerges as the highest bidder to acquire Natrol

12 Nov 2014 Evaluate

Aurobindo Pharma is currently trading at Rs. 1065.40, up by 37.30 points or 3.63% from its previous closing of Rs. 1028.10 on the BSE.

The scrip opened at Rs. 1028.00 and has touched a high and low of Rs. 1067.60 and Rs. 1028.00 respectively. So far 61588 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1067.60 on 12-Nov-2014 and a 52 week low of Rs. 265.15 on 12-Nov-2013.

Last one week high and low of the scrip stood at Rs. 1067.60 and Rs. 982.65 respectively. The current market cap of the company is Rs. 30710.18 crore.

The promoters holding in the company stood at 54.10% while Institutions and Non-Institutions held 35.67% and 10.22% respectively.

Aurobindo Pharma’s 100% subsidiary, Aurobindo Pharma USA Inc. emerged as the highest bidder for acquisition of nutritional supplement maker, Natrol Inc. and other affiliate entities (Natrol), under a process to be finally approved by the United States Bankruptcy Court for the District of Delaware.

Aurobindo USA believes that Natrol is an excellent strategic fit and provides the right platform for creating a fully-integrated OTC platform in the USA and in other international markets. Natrol, which manufactures and sells nutritional supplements in USA and other international market, provides Aurobindo with; Strong brand reputation and presence in a variety of attractive supplement markets; Proven performance in the mass market, health food and speciality channels; Existing long term relationship with key distribution and retail partners addressing a broad range of consumers and an effective growth strategy to expand market penetration.

The acquisition is subject to final approval by the US Court and other statutory approvals as may be required, including any termination of the waiting period or approval under the HSR Act, and closing conditions as per the Asset Purchase Agreement.  Barclays acted as the sole financial advisor and Sullivan & Cromwell LLP acted as the legal counsel to Aurobindo USA.

Aurobindo Pharma Share Price

1171.40 9.55 (0.82%)
10-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.25
Dr. Reddys Lab 1251.10
Cipla 1489.15
Zydus Lifesciences 923.70
Lupin 2055.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×